TACOMA GENERAL ALLENMORE HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11M
- Transactions
- 2,229
- Companies
- 40
- Average per transaction
- $4,928
Who reported the payments
| Merck | $2,118,473 |
| Eli Lilly | $1,802,611 |
| Gilead | $1,676,517 |
| AbbVie | $850,182 |
| Pfizer | $602,921 |
| Genentech, Inc. | $597,812 |
| Sanofi US Services Inc. | $374,033 |
| Rhythm Pharmaceuticals, Inc. | $234,655 |
| F. Hoffmann-la Roche AG | $185,286 |
| Luminex Corporation | $164,527 |
| Ares Trading SA | $113,744 |
| SK Life Science, Inc. | $111,687 |
| Zogenix Inc. | $99,942 |
| Novartis | $96,602 |
| Sanofi | $90,176 |
| Janssen Research & Development, LLC | $87,976 |
| Biontech SE | $86,113 |
| Artivion, Inc. | $72,943 |
| Regeneron | $72,712 |
| CSL Behring | $70,710 |
| Takeda Pharmaceuticals U.S.A., Inc. | $69,591 |
| Roche Diagnostics Operations, Inc. | $69,270 |
| OPKO Pharmaceuticals, LLC | $69,105 |
| Incyte Corporation | $64,104 |
| Astellas Pharma Global Development | $63,486 |
| Sanofi Pasteur Inc. | $52,365 |
| Tesaro, Inc. | $48,465 |
| Veru Inc. | $47,522 |
| Vanda Pharmaceuticals Inc. | $45,765 |
| Medical Device Business Services, Inc. | $42,866 |
| Mirati Therapeutics, Inc. | $40,740 |
| Genmark Diagnostics, Inc. | $38,722 |
| Stryker | $36,994 |
| Novocure Inc. | $36,521 |
| Alnylam Pharmaceuticals Inc. | $30,347 |
| Radius Health, Inc. | $29,681 |
| Acadia Pharmaceuticals Inc | $28,346 |
| Amryt Pharma Holdings Ltd | $27,119 |
| Ferring International Pharmascience Center US | $26,997 |
| KARL Storz Endoscopy-america | $26,843 |